Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas J. Falk files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Perry C. Siatis - $9.52M in ABBV purchases and sales in the last 12 months
- Nicholas Donoghoe - $8.18M in ABBV purchases and sales in the last 12 months
- John Frank A. St - $3.83M in LMT purchases and sales in the last 12 months
- David Ryan Purdue - $1.22M in ABBV purchases and sales in the last 12 months
- Robert M. Lightfoot Jr. - $118K in LMT purchases and sales in the last 12 months
- Stephanie C. Hill - $7K in LMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas J. Falk?
Thomas J. Falk is a corporate insider of AbbVie Inc. (ABBV). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas J. Falk last file a Form 4?
The most recent primary Form 4 on record is dated 12 May 2026, one of 3 filings going back to 2025.
